REG - MyCelx Tech. Corp. MyCelx Tech. Corp.. - Successful Trial of PFAS Remediation System

Mycelx TechnologiesAnnouncement

25/01/2022 07:05

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220125:nRSY4558Za&default-theme=true

RNS Number : 4558Z  MyCelx Technologies Corporation  25 January 2022

25 January 2022

MYCELX Technologies Corporation

 

Successful Trial of MYCELX's PFAS Remediation System

 

Reduction to non-detect levels highlights significant commercial opportunity
 

 

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water
and clean air technology company, is pleased to announce that it has
successfully completed a trial in the United States of its PFAS remediation
system which deploys its patented MYCELX technology. The results of the trial
confirm the ability of MYCELX's PFAS remediation system to reduce
contamination to non-detect level in a single pass through the system.

 

PFAS, which stands for perfluoroakyl and polyfluoroalkyl compounds, are a
collection of long-lasting man-made toxic chemicals, which present a threat to
the environment and human health. The Company estimates the annual PFAS
remediation cost in the United States to be in excess of US$8bn.

 

As part of its continuing strategy to address the PFAS remediation market,
MYCELX commenced an important trial at an industrial site in Newburgh, New
York, in December 2021. The trial involved treating PFAS contaminated water
from a storm water retention pond. The likely source of the PFAS contamination
was aqueous film forming foams (AFFF). The presence of additional
contaminants, such as glycols from plane de-icing procedures, ensured a
challenging and complex water source to remediate. MYCELX installed a mobile
trial system using the patented MYCELX technology for PFAS remediation.
Earlier generations of this technology have already been successfully deployed
in Australia, which is recognised as being at the forefront of PFAS
remediation. The MYCELX solution is designed to offer a lower life-cycle cost
of treatment, primarily due to significantly reduced waste versus alternative
technologies.

 

The trial successfully demonstrated the ability of the MYCELX system to
completely remove all detected chemicals to non-detectable concentrations in a
single pass, achieving a 99.99% removal efficiency.  Complete removal of this
spectrum of PFAS chemicals eliminates both regulated PFAS compounds, and
complete removal will prevent future degradation of components into PFAS
compounds that may be subject to future regulation. The technology provided a
failsafe treatment with no rise in differential pressures or increase in
outlet concentrations over the length of the trial.

 

Given the outlook for an increasingly strict regulatory climate for PFAS
contamination in North America, MYCELX, which was recently awarded the Green
Economy Mark by the London Stock Exchange for its contribution to the global
green economy, believes it is well placed to play an important role in the
global PFAS remediation challenge.

 

Connie Mixon, CEO of MYCELX, said:

 

"I am delighted to announce a successful outcome at our trial in the United
States, which further proves the viability of our PFAS remediation system, and
will pave the way for our entry into the US market. Our expansion in Australia
continues to gather momentum, with MYCELX technology currently deployed in
five commercial operations ranging from airports to military bases and with a
global oil supermajor.

 

With reliable and complete remediation of detectable PFAS chemicals, MYCELX
provides a breakthrough technological solution to remove a complete range of
PFAS types to below detectable levels. We believe this means that the
Company's offering not only has a significant technical advantage over its
competitors, but at a more cost-effective price point. This test result is an
important step forward in progressing towards our first commercial contract
for PFAS remediation in the United States."

 

For further information please contact:

 

 MYCELX Technologies Corporation

 Connie Mixon, CEO                     Tel: +1 888 306 6843

 Kim Slayton, CFO

 Canaccord Genuity, Nominated Adviser

 Henry Fitzgerald-O'Connor             Tel: + 44 20 7523 8000

 Georgina McCooke

 Celicourt

 Mark Antelme                          Tel: +44 20 8434 2754

 Jimmy Lea

 

 

The relevant notifications set out below are provided in accordance with the
requirements of Article 19 of the EU Market Abuse Regulation (No. 596/2014).

 

Notes to Editors

 

Through its revolutionary oil-free water technology, MYCELX brings its
customers material benefits in terms of performance enhancement, cost savings
and significantly improved environmental footprints. Working beyond any
ordinary filtration methods, MYCELX's proprietary technology achieves oil
removal to less than one part per million.  MYCELX supports leading
international customers across the oil & gas value chain, as well as other
industrial users.   MYCELX also provides advanced air filtration technology
for manufacturing and industrial facilities, effectively removing oil
particles and biologicals to maintain continuous and safe air quality levels.

 

For more information, visit www.MYCELX.com (http://www.MYCELX.com)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  STRUSUURUUUAUUR